tiprankstipranks
Advertisement
Advertisement

PRAX Stock Latest News

Praxis Precision initiated with an Outperform at RBC Capital
The FlyPraxis Precision initiated with an Outperform at RBC Capital
4d ago
PRAX
Praxis Precision Medicines Shareholders Back Directors and Governance
PremiumCompany Announcements
Praxis Precision Medicines Shareholders Back Directors and Governance
8d ago
8K
PRAX
Praxis Precision management to meet with Piper Sandler
PremiumThe Fly
Praxis Precision management to meet with Piper Sandler
11d ago
PRAX
Praxis Precision falls -15.4%
PremiumThe Fly
Praxis Precision falls -15.4%
19d ago
PRAX
Praxis Precision price target lowered to $616 from $715 at Truist
PremiumThe Fly
Praxis Precision price target lowered to $616 from $715 at Truist
19d ago
PRAX
Praxis Precision price target lowered to $650 from $750 at Oppenheimer
PremiumThe FlyPraxis Precision price target lowered to $650 from $750 at Oppenheimer
19d ago
PRAX
Praxis Precision price target lowered to $162 from $166 at Wedbush
Premium
The Fly
Praxis Precision price target lowered to $162 from $166 at Wedbush
19d ago
PRAX
Praxis Precision price target lowered to $810 from $843 at BTIG
Premium
The Fly
Praxis Precision price target lowered to $810 from $843 at BTIG
19d ago
PRAX
Praxis Precision price target lowered to $400 from $433 at Baird
PremiumThe Fly
Praxis Precision price target lowered to $400 from $433 at Baird
19d ago
PRAX
Buy Rating Reaffirmed as Higher Relutrigine Pricing Assumptions Offset Vormatrigine Setback; $537 Price Target Maintained
PremiumRatings
Buy Rating Reaffirmed as Higher Relutrigine Pricing Assumptions Offset Vormatrigine Setback; $537 Price Target Maintained
19d ago
PRAX
Yazdi Maintains Buy on Praxis, Trims Price Target to $810 as Vormatrigine Outlook Softens but Core Pipeline Thesis Remains Intact
PremiumRatings
Yazdi Maintains Buy on Praxis, Trims Price Target to $810 as Vormatrigine Outlook Softens but Core Pipeline Thesis Remains Intact
19d ago
PRAX
Praxis Precision price target lowered to $1,201 from $1,245 at H.C. Wainwright
PremiumThe Fly
Praxis Precision price target lowered to $1,201 from $1,245 at H.C. Wainwright
19d ago
PRAX
Praxis Precision price target lowered to $374 from $420 at Deutsche Bank
PremiumThe FlyPraxis Precision price target lowered to $374 from $420 at Deutsche Bank
19d ago
PRAX
Closing Bell Movers: HP Enterprise soars 28% after beat and raise
Premium
The Fly
Closing Bell Movers: HP Enterprise soars 28% after beat and raise
19d ago
FLR
HPE
Praxis Precision Reassesses Vormatrigine After Mixed POWER1 Data
Premium
Company Announcements
Praxis Precision Reassesses Vormatrigine After Mixed POWER1 Data
20d ago
8K
PRAX
Praxis Precision Medicines trading resumes
PremiumThe Fly
Praxis Precision Medicines trading resumes
20d ago
PRAX
Praxis Precision down 15% below $286 following POWER1 study update
PremiumThe Fly
Praxis Precision down 15% below $286 following POWER1 study update
20d ago
PRAX
Praxis Precision reports POWER1 study misses endpoint, pauses POWER2 enrollment
PremiumThe Fly
Praxis Precision reports POWER1 study misses endpoint, pauses POWER2 enrollment
20d ago
PRAX
Praxis Precision Medicines trading halted, news pending
PremiumThe Fly
Praxis Precision Medicines trading halted, news pending
20d ago
PRAX
Praxis Therapeutics: Strengthened Ulixacaltamide IP Underscores Franchise Durability; Buy Rating and $1,245 Price Target Reiterated
PremiumRatingsPraxis Therapeutics: Strengthened Ulixacaltamide IP Underscores Franchise Durability; Buy Rating and $1,245 Price Target Reiterated
26d ago
PRAX
Praxis Highlights FDA NDA Acceptances and Strengthened Cash Runway
Premium
Company Announcements
Praxis Highlights FDA NDA Acceptances and Strengthened Cash Runway
1M ago
8K
PRAX
Praxis Precision assumed with a Buy at Truist
Premium
The Fly
Praxis Precision assumed with a Buy at Truist
1M ago
PRAX

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >